Admera Health Expands Liquid Biopsy Offering to Include Detection of Copy Number Variation and Microsatellite Instability
October 23, 2018 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- At CAP18, in Chicago, IL, Admera Health (www.admerahealth.com), unveiled an expansion to its next generation sequencing (NGS) based...
Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
June 26, 2018 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com), announced the availability of a psychiatric specific report for its PGxOne™ Plus...
Admera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology Products
October 31, 2017 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com) announced the launch of multiple laboratory developed tests: PGxOnco™, for cancer supportive...